thiazoles has been researched along with zithromax in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Tuominen, RK; Vainio, PJ; Viluksela, M | 1 |
| Barchiesi, F; Burzacchini, F; Cirioni, O; Dini, M; Giacometti, A; Scalise, G | 1 |
| Ancarani, F; Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Cabada, MM; Pantenburg, B; White, AC | 1 |
| Rossignol, JF | 1 |
| Dalle, F; Deconinck, E; Grenouillet, F; Larosa, F; Legrand, F; Millon, L; Rohrlich, PS; Saas, P | 1 |
| Beamer, G; Campbell, MA; Girouard, D; Harwood, M; Lee, S; Meyers, MJ; Tzipori, S | 1 |
| DeBoer, MD; Donowitz, JR; Gratz, J; Houpt, ER; Jatosh, S; McDermid, JM; Mduma, E; Platts-Mills, JA; Scharf, RJ; Svensen, E; Swann, JR; Wanjuhi, AW | 1 |
| Kelleni, MT | 2 |
| DeBoer, MD; Donowitz, JR; Elwood, SE; Gratz, J; Houpt, ER; Jatosh, S; Katengu, S; Kivuyo, S; McDermid, JM; Mdoe, P; Mduma, E; Parpia, TC; Platts-Mills, JA; Rogawski McQuade, ET; Scharf, RJ; Svensen, E; Swann, JR; Wanjuhi, AW | 2 |
| Bayo, E; Blacy, L; DeBoer, M; Elwood, S; Houpt, E; Mduma, E; Parpia, T; Platts-Mills, J; Rogawski McQuade, E; Scharf, R; Svensen, E; Wanjuhi, A | 1 |
1 review(s) available for thiazoles and zithromax
| Article | Year |
|---|---|
Treatment of cryptosporidiosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiretroviral Therapy, Highly Active; Azithromycin; Biliary Tract Diseases; Coccidiostats; Cryptosporidiosis; Humans; Immunocompromised Host; Nitro Compounds; Paromomycin; Rifamycins; Rifaximin; Thiazoles | 2009 |
4 trial(s) available for thiazoles and zithromax
| Article | Year |
|---|---|
Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamide.
Topics: Administration, Oral; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Breast Feeding; Double-Blind Method; Female; Growth and Development; Humans; Infant; Infant, Newborn; Male; Mothers; Niacinamide; Nitro Compounds; Randomized Controlled Trials as Topic; Tanzania; Thiazoles; Vitamin B Complex | 2018 |
Baseline Characteristics of Study Participants in the Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT) Trial.
Topics: Adult; Azithromycin; Body Weight; Child Health; Child Nutrition Disorders; Child, Preschool; Cohort Studies; Early Medical Intervention; Female; Humans; Infant; Infant, Newborn; Male; Mothers; Neonatal Sepsis; Niacinamide; Nitro Compounds; Poverty; Respiratory Tract Infections; Rural Population; Seasons; Surveys and Questionnaires; Tanzania; Thiazoles; Young Adult | 2020 |
Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: A factorial randomized, double-blind, placebo-controlled trial.
Topics: Adult; Anti-Infective Agents; Azithromycin; Child Development; Double-Blind Method; Drug Administration Schedule; Female; Growth Disorders; Humans; Infant; Infant, Newborn; Intestinal Diseases, Parasitic; Niacinamide; Nitro Compounds; Pregnancy; Tanzania; Thiazoles | 2021 |
Cognitive Outcomes at 18 Months: Findings from the Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT) Trial.
Topics: Anti-Infective Agents; Antiparasitic Agents; Azithromycin; Child Development; Cognitive Aging; Cohort Studies; Early Intervention, Educational; Female; Humans; Infant; Male; Niacinamide; Nitro Compounds; Seasons; Tanzania; Thiazoles; Vitamin B Complex | 2021 |
8 other study(ies) available for thiazoles and zithromax
| Article | Year |
|---|---|
Cytotoxicity of macrolide antibiotics in a cultured human liver cell line.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Epithelial Cells; Epithelium; Erythromycin; Humans; Liver; Proteins; Roxithromycin; Tetrazolium Salts; Thiazoles | 1996 |
Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Azithromycin; Cryptosporidiosis; Cryptosporidium; Drug Therapy, Combination; Feces; Female; Humans; Nitro Compounds; Paromomycin; Thiazoles; Treatment Outcome | 1999 |
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cell Survival; Cells, Cultured; Cryptosporidiosis; Cryptosporidium parvum; Humans; Nitro Compounds; Rifabutin; Thiazoles | 2000 |
Cryptosporidium and Giardia: treatment options and prospects for new drugs.
Topics: AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antiparasitic Agents; Antiretroviral Therapy, Highly Active; Azithromycin; Benzimidazoles; Cryptosporidiosis; Giardia lamblia; Giardiasis; Humans; Nitro Compounds; Nitroimidazoles; Paromomycin; Roxithromycin; Thiazoles | 2010 |
Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stem cell transplant recipients: a prospective single centre study.
Topics: Adult; Animals; Azithromycin; Cryptosporidiosis; Cryptosporidium parvum; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Lymphopenia; Male; Middle Aged; Nitro Compounds; Thiazoles; Transplantation, Homologous; Young Adult | 2011 |
The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Cryptosporidiosis; Cryptosporidium; Disease Models, Animal; Drug Therapy, Combination; Nitro Compounds; Sus scrofa; Swine; Thiazoles; Treatment Outcome | 2017 |
Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management.
Topics: Antiparasitic Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Thiazoles | 2020 |
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Repositioning; Humans; Interferons; Interleukin-6; Nitro Compounds; Observational Studies as Topic; SARS-CoV-2; Thiazoles | 2022 |